|
2025
|
Invention
|
Use of the recombinant fibrinogen-like domain of angiopoietin-like 4 for treating sepsis capillar... |
|
|
Invention
|
Anti-ifn-α2 and anti-ifn-ω1 monoclonal antibodies. The invention relates to novel monoclonal anti... |
|
|
Invention
|
Anti-ifn-α2 monoclonal antibodies. The invention relates to novel monoclonal antibodies that bind... |
|
|
Invention
|
Anti-ifn-omega1 monoclonal antibodies. The invention relates to novel monoclonal antibodies that ... |
|
|
Invention
|
Use of transferrin-receptor large extracellular vesicles as biomarkers of metabolic-dysfunction a... |
|
|
Invention
|
Byl719 (alpelisib) for use in the treatment of pik3ca-related overgrowth spectrum (pros-cloves sy... |
|
|
Invention
|
Methods for assessing risk of developing a viral disease using a genetic test.
This document pro... |
|
|
Invention
|
Methods and pharmaceutical composition for the treatment of uterine disease. Control tissues and ... |
|
|
Invention
|
Method for predicting the response to a bipolar disorder treatement. The invention relates to the... |
|
|
Invention
|
Method for determining the age of red blood cells. Glycated Hb was measured in reticulocytes (RNA... |
|
|
Invention
|
Methods and pharmaceutical composition for treating cancers. Inventors demonstrated that an epige... |
|
|
Invention
|
Use of soluble trem-1 as a biomarker for assessing the risk of cardiovascular disease in asymptom... |
|
|
Invention
|
Use of vdac and lamp1 as markers for detecting pocked red blood cells. OF THE INVENTION USE OF VD... |
|
|
Invention
|
Device and method for generating n virtual immunohistochemical (ihc) stain images from one hemato... |
|
|
Invention
|
Ravidasvir, velpatasvir, and elbasvir for blocking transmission of plasmodium gametocytes. Plasmo... |
|
|
Invention
|
Method and pharmaceutical composition for use in the treatment of nutritional liver diseases or m... |
|
|
Invention
|
Methods for the intravenous treatment of sanfilippo syndrome type iiib. The present invention rel... |
|
|
Invention
|
Process for multi-analyses of rare cells extracted or isolated from biological samples through fi... |
|
2024
|
Invention
|
The use of nme1/2 inhibitors in methods of treating ß-hemoglobinopathies. BCL11A plays a critical... |
|
|
Invention
|
Methods and compositions for treating diseases or conditions induced by corticosteroids, synovial... |
|
|
Invention
|
Method for analysing a multispectral video previously acquired by endoscopy performed on a region... |
|
|
Invention
|
Methods and compositions for treating cellular senescence. AA receptor γ2 subunit. In some instan... |
|
|
Invention
|
Cd5 targeting antibodies with depleting and t or b-cell activation effects. The CD5 antigen (or "... |
|
|
Invention
|
New method to treat brain or neurologic disorders. The present invention relates to the treatment... |
|
|
Invention
|
Method to predict the risk of a cardiovascular event in a patient with type 2 diabetes. The prese... |
|
|
Invention
|
Use of amoebae for the treatment of metabolic syndrome. Metabolic syndrome (MS) is a clustering o... |
|
|
Invention
|
Device for obtaining a trained machine learning segmentation model for pulvinar segmentation and ... |
|
|
Invention
|
Use of ykl-40 as a biomarker for assessing functional outcome in acute ischemic stroke patients t... |
|
|
Invention
|
Combination of pak1 inhibitors and clk inhibitors for preventing resistance to chemotherapy in pa... |
|
|
Invention
|
Use of artificial marrow organoid for generating nk cells and myeloid cells. The human bone marro... |
|
|
Invention
|
Inhibitor of the transcription factor ap-1 for use in the treatment of age-related diseases. The ... |
|
|
Invention
|
Devices for generation of synthetic 3d representations of myelin content. The present invention r... |
|
|
Invention
|
Treatment of ciliopathies and ciliary dysfunctions. The present invention relates to the treatmen... |
|
|
Invention
|
Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due... |
|
|
Invention
|
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy du... |
|
|
Invention
|
Langerhans cells targeting hiv-1 vaccines. Developing an effective HIV-1 vaccine is contingent on... |
|
|
Invention
|
Methods of predicting the risk of recurrence and/or death of patients suffering from a hepatocell... |
|
2023
|
Invention
|
Methods for assessing the exhaustion of hematopoietic stem cells induced by chronic inflammation.... |
|
|
Invention
|
Base editing approaches for correcting the cd39 (cag>tag) mutation in patients suffering from bet... |
|
|
Invention
|
Syncitin-1 fusion proteins and uses thereof for cargo delivery into target cells.
The inventors ... |
|
|
Invention
|
Gene therapy for the treatment of activated pi3kinase delta syndrome type 1 (apds1).
The present... |
|
|
Invention
|
Methods for the diagnosis and treatment of t-cell malignancies.
T-cell malignancies are a broad,... |
|
|
Invention
|
Use of tcr-deficient car-tregs in combination with anti-tcr complex monoclonal antibodies for ind... |
|
|
Invention
|
Base editing approaches for the treatment of beta-thalassemia.
IVS1-110 (G>A) is one of the most... |
|
2022
|
Invention
|
Use of trem-1 for predicting and preventing postoperative complications after cardiac surgery wit... |
|
|
Invention
|
Use of il-36 inhibitors for the treatment of netherton syndrome.
Netherton syndrome (NS) is a ra... |
|
2021
|
Invention
|
Methods for treating notch1-driven cancers.
T-cell acute lymphoblastic leukemias (T-ALL) are agg... |
